November 1, 2017
Following the new report released by the President’s Commission on Combating Drug Addiction and the Opioid Crisis, Healthcare Distribution Alliance (HDA) President and CEO John M. Gray released the following statement.
“We commend the Commission for its work over the past several months to identify comprehensive solutions to address the opioid epidemic. Our industry is strongly committed to working with the public and private sectors to advance meaningful reforms at both the state and federal levels to reduce the prevalence of overprescribing; increase awareness of proper use and disposal of opioids among patients and families; and ensure individuals with legitimate pain needs have access to safe and effective treatments.
“In our letter to the Commission, we outlined the proactive solutions that would strengthen our country’s response to this epidemic. We were encouraged to see the Commission call for urgent action on a number of these policies, including:
“The recommendations from the Commission, coupled with those of The National Academies of Sciences, Engineering, and Medicine released this summer, provide a strong blueprint for how we can comprehensively address the epidemic moving forward.”
The Healthcare Distribution Alliance (HDA) represents primary pharmaceutical distributors — the vital link between the nation’s pharmaceutical manufacturers and more than 200,000 pharmacies, hospitals, long-term care facilities, clinics and others nationwide. Since 1876, HDA has helped members navigate regulations and innovations to get the right medicines to the right patients at the right time, safely and efficiently. The HDA Research Foundation, HDA’s non-profit charitable foundation, serves the healthcare industry by providing research and education focused on priority healthcare supply chain issues.